CervoMed Inc. (CRVO)
Healthcare
Biotechnology
2.60 $
+2.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns CervoMed Inc. (CRVO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 65.5% of the shares are freely tradable; institutional investors hold 13.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
13.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
29.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
65.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
9Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Morgan Stanley - Brokerage Accounts | 7.99 | 739,892 | +55.9 | 03/31/2026 |
| Vanguard Group Inc | 3.83 | 354,950 | +3.3 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.42 | 316,202 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 2.26 | 208,908 | +246.6 | 03/31/2026 |
| Geode Capital Management, LLC | 0.80 | 74,371 | +12.9 | 03/31/2026 |
| Renaissance Technologies Corp | 0.69 | 63,904 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.56 | 51,660 | +5.1 | 03/31/2026 |
| XTX Topco Ltd | 0.42 | 38,487 | +273.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.70 | 250,174 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.71 | 66,028 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.